DGAT1 and neoplasm: Notably, DGAT1 inhibition significantly impairs tumor growth in melanoma-B16F10 and Lewis lung carcinam-LLC models in C57/BL6 mice, highlighting its potential as a therapeutic target warranting further investigation (Fig. 6 and Table 7).